Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO

April 30, 2026

Read the article here.

Related News

See All News

Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion

Biotechnology

May 6, 2026

Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion

Servier to Buy Day One for $2.5 Billion, Expanding Oncology Portfolio

Biotechnology

March 6, 2026

Servier to Buy Day One for $2.5 Billion, Expanding Oncology Portfolio

How Disc Medicine Rescued a Discarded Drug Candidate

Biotechnology

November 24, 2025

How Disc Medicine Rescued a Discarded Drug Candidate

Access Industries is a privately-held, global investment company. Founded in 1986, by businessman and philanthropist Len Blavatnik, Access identifies companies with strong business models and management teams, and optimizes their value through financial backing and expertise.

New York Office

40 West 57th Street
28th Floor
New York, NY 10019
+1 212 247 6400

London Office

6th Floor
Marble Arch House
66 Seymour Street
London, W1H 5BT
+44 207 569 8686

Legal

Further Information

Contact Us
News
Our Story
Blavatnik Family Foundation
Blavatnik Archive

Holdings

Biotechnology
Entertainment
Global Media
Real Estate
Strategic Equity
Technology Ventures
External Funds

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled